AVEO Oncology
AVEO
#7099
Rank
C$0.72 B
Marketcap
C$20.72
Share price
0.00%
Change (1 day)
164.39%
Change (1 year)

AVEO Oncology (AVEO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : C$0.10 Billion

According to AVEO Oncology 's latest financial reports the company's total liabilities are C$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31C$75.79 M88%
2020-12-31C$40.31 M-13.67%
2019-12-31C$46.69 M-37.85%
2018-12-31C$75.14 M-34.29%
2017-12-31C$0.11 B191.36%
2016-12-31C$39.25 M21.36%
2015-12-31C$32.34 M-44.32%
2014-12-31C$58.08 M-28.58%
2013-12-31C$81.33 M-7.61%
2012-12-31C$88.03 M21.03%
2011-12-31C$72.73 M-8.21%
2010-12-31C$79.24 M4.65%
2009-12-31C$75.72 M-63.1%
2008-12-31C$0.20 B23.84%
2007-12-31C$0.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
C$15.19 B 15,095.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$12.72 B 12,625.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$31.32 M-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$108.15 B 108,051.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$125.83 B 125,728.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$111.24 B 111,136.67%๐Ÿ‡บ๐Ÿ‡ธ USA